Zura narrows focus to tibulizumab, launches two Phase 2 trials, settles finder fees for $46M
Filed March 19, 2026 · Period ending December 31, 2025 · Compared to 10-K Mar 25, 2025 · ~2 min read
5 material changes detected in this filing.
Create a free account to read the full summary — it takes 30 seconds.
Partner
Trade ZURA commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Generated by AI · Jun 4, 2026 7:33 PM